tiprankstipranks
Spyre Therapeutics, Inc (SYRE)
NASDAQ:SYRE
US Market
SYRE
Spyre Therapeutics
RESEARCH TOOLSreports

Spyre Therapeutics (SYRE) Stock News & Sentiment

534 Followers
Spyre Therapeutics Pauses At-The-Market Equity Offering Program
Premium
Company Announcements
Spyre Therapeutics Pauses At-The-Market Equity Offering Program
1d ago
8K
SYRE
Buy Rating on SYRE: Early SPY001 Outperformance, Broad IBD Opportunity, and Catalyst‑Rich Path Support Higher $80 Target
Premium
Ratings
Buy Rating on SYRE: Early SPY001 Outperformance, Broad IBD Opportunity, and Catalyst‑Rich Path Support Higher $80 Target
1d ago
SYRE
Spyre Therapeutics Reports Positive Phase 2 SKYLINE Results
Premium
Company Announcements
Spyre Therapeutics Reports Positive Phase 2 SKYLINE Results
2d ago
8K
SYRE
Spyre Therapeutics Completes First-in-Human Study of SPY001-001, De-risking Early Pipeline
Premium
Company Announcements
Spyre Therapeutics Completes First-in-Human Study of SPY001-001, De-risking Early Pipeline
25d ago
SYRE
Spyre Therapeutics: Undervalued TL1A Leader With Accelerating Clinical Momentum and Near‑Term Catalysts
Premium
Ratings
Spyre Therapeutics: Undervalued TL1A Leader With Accelerating Clinical Momentum and Near‑Term Catalysts
29d ago
SYRE
3 ‘Strong Buy’ Stocks to Buy in Today’s Volatile Market, 2/23/2026, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy in Today’s Volatile Market, 2/23/2026, According to Top Analysts
2M ago
HOOD
NVDA
Spyre Therapeutics: Rich 12-Month Catalyst Calendar and Differentiated IBD Portfolio Support Buy Rating
Premium
Ratings
Spyre Therapeutics: Rich 12-Month Catalyst Calendar and Differentiated IBD Portfolio Support Buy Rating
2M ago
SYRE
More SYRE News >

SYRE News on the Web

Analysts Are Bullish on Top Healthcare Stocks: Delcath Systems (DCTH), HeartFlow, Inc. (HTFL)
TipRanks News
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alfresa Holdings (OtherARHCF), Spyre Therapeutics (SYRE) and Eisai Co (OtherESALF)
TipRanks News
Bullish
Spyre Therapeutics price target raised to $90 from $65 at Baird
TipRanks News
Bullish
Spyre Therapeutics price target raised to $90 from $50 at Wells Fargo
TipRanks News
Bullish
Spyre Therapeutics price target raised to $88 from $55 at Deutsche Bank
TipRanks News
Bullish
Spyre Therapeutics (SYRE) Launches $300M Public Offering to Fund Treatment Development
GuruFocus News
Bullish
Closing Bell Movers: Bloom Energy spikes on expanded Oracle deal
TipRanks News
Bearish
Spyre Therapeutics announces $300M offering of common stock
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
SYRE
Sector Average
Media Buzz
This Week30 articles
Weekly Average11.25 articles
News Sentiment
This Week99%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SYRE’s Media Buzz Sentiment?
30 articles about SYRE were published this week. In an average week, 11.25 articles are published.
    What is SYRE’s weekly average amount of articles?
    In an average week, 11.25 articles about SYRE are published.
      What is SYRE’s News Sentiment?
      99% of articles about SYRE were positive this week, compared to its sector average of 67%.
        Healthcare Stocks that are Trending in the News
        TXTMProText Mobility
        ALLOAllogene Therapeutics
        REPLReplimune Group
        IVVDInvivyd
        SLPSimulations Plus
        Showing the stocks with the most bullish news sentiment over the past week